Preissner K T
Clinical Research Unit for Blood Coagulation and Thrombosis, Max-Planck-Gesellschaft, Justus Liebig University, Giessen, FRG.
Haemostasis. 1988;18(4-6):271-300. doi: 10.1159/000215813.
In this communication some of the important regulatory mechanisms involving endothelial cell surface associated anticoagulant reactions as well as endothelial cell surface expressed receptors which directly contribute to the inhibition of coagulation are reviewed. In particular, the mechanism of action of protease inhibitors such as antithrombin III, heparin cofactor II, or protease nexin I and their possible interaction with glycosaminoglycan components of the endothelial cells is critically summarized. Thrombin binding to endothelial cells, in particular to thrombomodulin, is believed to be a major event in the induction of anticoagulatory mechanisms such as the protein C/protein S system which warrant a balanced hemostatic system. Additional components such as vascular anticoagulant or extrinsic pathway inhibitor may also contribute to the anticoagulant potential of the vessel wall. Furthermore, the modulation of these membrane-associated anticoagulant reactions by other components such as heparin-binding proteins is discussed.
在本通讯中,我们综述了一些重要的调节机制,这些机制涉及内皮细胞表面相关的抗凝反应以及直接有助于抑制凝血的内皮细胞表面表达的受体。特别地,我们批判性地总结了蛋白酶抑制剂(如抗凝血酶III、肝素辅因子II或蛋白酶连接素I)的作用机制及其与内皮细胞糖胺聚糖成分的可能相互作用。凝血酶与内皮细胞结合,特别是与血栓调节蛋白结合,被认为是诱导抗凝机制(如蛋白C/蛋白S系统)的一个主要事件,该系统保证了止血系统的平衡。其他成分,如血管抗凝剂或外源性途径抑制剂,也可能有助于血管壁的抗凝潜力。此外,还讨论了其他成分(如肝素结合蛋白)对这些膜相关抗凝反应的调节作用。